Fear can take over the moment prostate cancer progresses. These questions can help caregivers replace confusion with clarity, ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

ASCO 2026 plenary data establishes daraxonrasib as the new second-line standard of care for advanced pancreatic tumors.

Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.

Patients with multiple myeloma who received a new immunotherapy combination lived significantly longer without their cancer ...

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...

Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for ...

Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...

The FDA has approved capivasertib (Truqap) in combination with abiraterone acetate (Zytiga) and prednisone for adults with ...